| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 13.35B | 11.84B | 11.48B | 12.54B | 11.85B |
| Gross Profit | 6.50B | 5.50B | 5.11B | 5.51B | 5.30B |
| EBITDA | 7.25B | 7.63B | 12.54B | 6.20B | 7.47B |
| Net Income | 6.50B | 7.98B | 6.42B | 8.01B | 8.37B |
Balance Sheet | |||||
| Total Assets | 177.53B | 169.47B | 172.31B | 172.16B | 178.69B |
| Cash, Cash Equivalents and Short-Term Investments | 11.74B | 14.18B | 15.67B | 9.63B | 9.98B |
| Total Debt | 36.29B | 34.55B | 37.49B | 35.48B | 37.71B |
| Total Liabilities | 50.50B | 48.04B | 51.47B | 55.83B | 60.13B |
| Stockholders Equity | 110.40B | 105.35B | 103.68B | 96.97B | 98.26B |
Cash Flow | |||||
| Free Cash Flow | 8.60B | 7.35B | 4.67B | 5.94B | 5.74B |
| Operating Cash Flow | 9.47B | 8.55B | 5.98B | 7.46B | 7.57B |
| Investing Cash Flow | -2.50B | 345.00M | 2.57B | -3.82B | -4.08B |
| Financing Cash Flow | -6.89B | -9.64B | -7.11B | -4.90B | -6.13B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | HK$63.69B | 7.14 | 11.51% | 5.34% | 1.02% | 0.36% | |
75 Outperform | HK$20.63B | 6.93 | 7.93% | 3.47% | 6.08% | 5.81% | |
73 Outperform | HK$66.33B | 5.50 | 5.92% | 5.72% | 12.77% | -18.46% | |
73 Outperform | HK$38.71B | 9.45 | 3.62% | 3.23% | 8.66% | 53.27% | |
69 Neutral | HK$4.43B | 3.20 | 4.48% | 6.69% | -14.81% | -3.39% | |
67 Neutral | HK$20.79B | 7.64 | 4.96% | 4.97% | 10.25% | -9.65% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |